Cargando…
A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells
Non-alcoholic fatty liver disease comprises a broad spectrum of disease states ranging from simple steatosis to non-alcoholic steatohepatitis. As a result of increases in the prevalences of obesity, insulin resistance, and hyperlipidemia, the number of people with hepatic steatosis continues to incr...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432516/ https://www.ncbi.nlm.nih.gov/pubmed/22969728 http://dx.doi.org/10.3389/fphys.2012.00339 |
_version_ | 1782242217955426304 |
---|---|
author | Jozefczuk, Justyna Kashofer, Karl Ummanni, Ramesh Henjes, Frauke Rehman, Samrina Geenen, Suzanne Wruck, Wasco Regenbrecht, Christian Daskalaki, Andriani Wierling, Christoph Turano, Paola Bertini, Ivano Korf, Ulrike Zatloukal, Kurt Westerhoff, Hans V. Lehrach, Hans Adjaye, James |
author_facet | Jozefczuk, Justyna Kashofer, Karl Ummanni, Ramesh Henjes, Frauke Rehman, Samrina Geenen, Suzanne Wruck, Wasco Regenbrecht, Christian Daskalaki, Andriani Wierling, Christoph Turano, Paola Bertini, Ivano Korf, Ulrike Zatloukal, Kurt Westerhoff, Hans V. Lehrach, Hans Adjaye, James |
author_sort | Jozefczuk, Justyna |
collection | PubMed |
description | Non-alcoholic fatty liver disease comprises a broad spectrum of disease states ranging from simple steatosis to non-alcoholic steatohepatitis. As a result of increases in the prevalences of obesity, insulin resistance, and hyperlipidemia, the number of people with hepatic steatosis continues to increase. Differences in susceptibility to steatohepatitis and its progression to cirrhosis have been attributed to a complex interplay of genetic and external factors all addressing the intracellular network. Increase in sugar or refined carbohydrate consumption results in an increase of insulin and insulin resistance that can lead to the accumulation of fat in the liver. Here we demonstrate how a multidisciplinary approach encompassing cellular reprogramming, transcriptomics, proteomics, metabolomics, modeling, network reconstruction, and data management can be employed to unveil the mechanisms underlying the progression of steatosis. Proteomics revealed reduced AKT/mTOR signaling in fibroblasts derived from steatosis patients and further establishes that the insulin-resistant phenotype is present not only in insulin-metabolizing central organs, e.g., the liver, but is also manifested in skin fibroblasts. Transcriptome data enabled the generation of a regulatory network based on the transcription factor SREBF1, linked to a metabolic network of glycerolipid, and fatty acid biosynthesis including the downstream transcriptional targets of SREBF1 which include LIPIN1 (LPIN) and low density lipoprotein receptor. Glutathione metabolism was among the pathways enriched in steatosis patients in comparison to healthy controls. By using a model of the glutathione pathway we predict a significant increase in the flux through glutathione synthesis as both gamma-glutamylcysteine synthetase and glutathione synthetase have an increased flux. We anticipate that a larger cohort of patients and matched controls will confirm our preliminary findings presented here. |
format | Online Article Text |
id | pubmed-3432516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34325162012-09-11 A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells Jozefczuk, Justyna Kashofer, Karl Ummanni, Ramesh Henjes, Frauke Rehman, Samrina Geenen, Suzanne Wruck, Wasco Regenbrecht, Christian Daskalaki, Andriani Wierling, Christoph Turano, Paola Bertini, Ivano Korf, Ulrike Zatloukal, Kurt Westerhoff, Hans V. Lehrach, Hans Adjaye, James Front Physiol Physiology Non-alcoholic fatty liver disease comprises a broad spectrum of disease states ranging from simple steatosis to non-alcoholic steatohepatitis. As a result of increases in the prevalences of obesity, insulin resistance, and hyperlipidemia, the number of people with hepatic steatosis continues to increase. Differences in susceptibility to steatohepatitis and its progression to cirrhosis have been attributed to a complex interplay of genetic and external factors all addressing the intracellular network. Increase in sugar or refined carbohydrate consumption results in an increase of insulin and insulin resistance that can lead to the accumulation of fat in the liver. Here we demonstrate how a multidisciplinary approach encompassing cellular reprogramming, transcriptomics, proteomics, metabolomics, modeling, network reconstruction, and data management can be employed to unveil the mechanisms underlying the progression of steatosis. Proteomics revealed reduced AKT/mTOR signaling in fibroblasts derived from steatosis patients and further establishes that the insulin-resistant phenotype is present not only in insulin-metabolizing central organs, e.g., the liver, but is also manifested in skin fibroblasts. Transcriptome data enabled the generation of a regulatory network based on the transcription factor SREBF1, linked to a metabolic network of glycerolipid, and fatty acid biosynthesis including the downstream transcriptional targets of SREBF1 which include LIPIN1 (LPIN) and low density lipoprotein receptor. Glutathione metabolism was among the pathways enriched in steatosis patients in comparison to healthy controls. By using a model of the glutathione pathway we predict a significant increase in the flux through glutathione synthesis as both gamma-glutamylcysteine synthetase and glutathione synthetase have an increased flux. We anticipate that a larger cohort of patients and matched controls will confirm our preliminary findings presented here. Frontiers Research Foundation 2012-09-03 /pmc/articles/PMC3432516/ /pubmed/22969728 http://dx.doi.org/10.3389/fphys.2012.00339 Text en Copyright © 2012 Jozefczuk, Kashofer, Ummanni, Henjes, Rehman, Geenen, Wruck, Regenbrecht, Daskalaki, Wierling, Turano, Bertini, Korf, Zatloukal, Westerhoff, Lehrach and Adjaye. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
spellingShingle | Physiology Jozefczuk, Justyna Kashofer, Karl Ummanni, Ramesh Henjes, Frauke Rehman, Samrina Geenen, Suzanne Wruck, Wasco Regenbrecht, Christian Daskalaki, Andriani Wierling, Christoph Turano, Paola Bertini, Ivano Korf, Ulrike Zatloukal, Kurt Westerhoff, Hans V. Lehrach, Hans Adjaye, James A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells |
title | A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells |
title_full | A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells |
title_fullStr | A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells |
title_full_unstemmed | A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells |
title_short | A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells |
title_sort | systems biology approach to deciphering the etiology of steatosis employing patient-derived dermal fibroblasts and ips cells |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432516/ https://www.ncbi.nlm.nih.gov/pubmed/22969728 http://dx.doi.org/10.3389/fphys.2012.00339 |
work_keys_str_mv | AT jozefczukjustyna asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT kashoferkarl asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT ummanniramesh asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT henjesfrauke asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT rehmansamrina asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT geenensuzanne asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT wruckwasco asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT regenbrechtchristian asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT daskalakiandriani asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT wierlingchristoph asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT turanopaola asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT bertiniivano asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT korfulrike asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT zatloukalkurt asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT westerhoffhansv asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT lehrachhans asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT adjayejames asystemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT jozefczukjustyna systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT kashoferkarl systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT ummanniramesh systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT henjesfrauke systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT rehmansamrina systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT geenensuzanne systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT wruckwasco systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT regenbrechtchristian systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT daskalakiandriani systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT wierlingchristoph systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT turanopaola systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT bertiniivano systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT korfulrike systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT zatloukalkurt systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT westerhoffhansv systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT lehrachhans systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells AT adjayejames systemsbiologyapproachtodecipheringtheetiologyofsteatosisemployingpatientderiveddermalfibroblastsandipscells |